Biotricity (NASDAQ:BTCY) Trading 6.9% Higher – Time to Buy?

Biotricity, Inc. (NASDAQ:BTCY) was up 6.9% during mid-day trading on Thursday . The stock traded as high as $0.33 and last traded at $0.31. Approximately 104,856 shares traded hands during mid-day trading, an increase of 37% from the average daily volume of 76,434 shares. The stock had previously closed at $0.29.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a “neutral” rating on shares of Biotricity in a research report on Monday, November 18th.

Biotricity Stock Up 6.9 %

The firm’s 50-day moving average price is $0.32 and its 200 day moving average price is $0.46. The firm has a market cap of $7.61 million, a P/E ratio of -0.23 and a beta of 1.14.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Biotricity stock. AE Wealth Management LLC acquired a new position in shares of Biotricity, Inc. (NASDAQ:BTCY) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned 0.45% of Biotricity at the end of the most recent quarter. Hedge funds and other institutional investors own 3.89% of the company’s stock.

About Biotricity

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.